Zhejiang NHU Company Ltd.
002001
株式のランク
#1805
Zhejiang NHU Company Ltd., founded in 1999 and headquartered in Xinchang,... Zhejiang NHU Company Ltd., founded in 1999 and headquartered in Xinchang, China, specializes in the nationwide production and distribution of a broad spectrum of chemical products. Its principal operations are divided into four main categories: 1. Nutritional Products: The company offers a comprehensive range of supplements, including essential vitamins (E, A, C, D3, biotin), DL-Methionine, coenzyme Q10, and various carotenoids. These ingredients are critical for enhancing animal feed and fortifying food, beverages, and health-related products. 2. Flavors and Fragrances: This segment supplies a variety of aroma chemicals, such as derivatives from the linalool and citral series, cis-3-hexenol, methyl dihydrojasmonate, raspberry ketone, and ligustral, which are widely utilized in personal care items, cosmetic formulations, and food flavorings. 3. New Polymer Materials: Zhejiang NHU provides advanced polymer solutions like polyphenylene sulfide and polyphthalamide. These materials find essential applications across industries including electronics, automotive manufacturing, and environmental protection. 4. Active Pharmaceutical Ingredients (APIs): The company manufactures crucial pharmaceutical components, including moxifloxacin hydrochloride, vitamin A, and vitamin D3, which serve as foundational substances for the development and production of various drug preparations.
株価
$3.84
時価総額
$11.80B
変化（1日）
0.70%
変化（1年）
17.47%
国
CN
取引 Zhejiang NHU Company Ltd. (002001)
カテゴリー
Healthcare
Zhejiang NHU Company Ltd.（002001）の収益
Jun 2026 時点の収益 TTM: $3.52B
Zhejiang NHU Company Ltd. の最新の財務報告によると、現在の収益 (TTM) は $3.52B です。2023 年には $2.14B の収益があり、これは 2022 年の $2.31B と比較して 減少 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Zhejiang NHU Company Ltd. の収益履歴（2001 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $3.52B | 18.85% |
| 2024 | $2.96B | 38.63% |
| 2023 | $2.14B | -7.55% |
| 2022 | $2.31B | -1.58% |
| 2021 | $2.35B | 48.65% |
| 2020 | $1.58B | 43.52% |
| 2019 | $1.10B | -12.85% |
| 2018 | $1.26B | 31.73% |
| 2017 | $958.33M | 41.68% |
| 2016 | $676.41M | 14.91% |
| 2015 | $588.65M | -12.44% |
| 2014 | $672.30M | -3.77% |
| 2013 | $698.61M | 19.97% |
| 2012 | $582.35M | -2.72% |
| 2011 | $598.62M | 14.68% |
| 2010 | $521.97M | 22.96% |
| 2009 | $424.51M | -12.59% |
| 2008 | $485.66M | 102.88% |
| 2007 | $239.38M | 17.59% |
| 2006 | $203.56M | 30.76% |
| 2005 | $155.68M | 13.60% |
| 2004 | $137.04M | 19.26% |
| 2003 | $114.91M | 37.58% |
| 2002 | $83.52M | 28.20% |
| 2001 | $65.15M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 87.91% |
IN
|
